HUP0500161A2 - Cirkovírusok tenyésztésére szolgáló eljárás - Google Patents

Cirkovírusok tenyésztésére szolgáló eljárás

Info

Publication number
HUP0500161A2
HUP0500161A2 HU0500161A HUP0500161A HUP0500161A2 HU P0500161 A2 HUP0500161 A2 HU P0500161A2 HU 0500161 A HU0500161 A HU 0500161A HU P0500161 A HUP0500161 A HU P0500161A HU P0500161 A2 HUP0500161 A2 HU P0500161A2
Authority
HU
Hungary
Prior art keywords
mammalian
circovirus
methods
replication
cells
Prior art date
Application number
HU0500161A
Other languages
English (en)
Inventor
Qiang Liu
Suresh K. Tikoo
Philip Willson
Lorne A. Babiuk
Original Assignee
University Of Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Saskatchewan filed Critical University Of Saskatchewan
Publication of HUP0500161A2 publication Critical patent/HUP0500161A2/hu
Publication of HUP0500161A3 publication Critical patent/HUP0500161A3/hu
Publication of HU228065B1 publication Critical patent/HU228065B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10051—Methods of production or purification of viral material
    • C12N2750/10052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A jelen találmány tárgyát emlős cirkovírusok tenyésztésére szolgálóeljárások képezik, amely eljárások tartalmazzák az alábbi lépéseket:a) olyan emlőssejtek biztosítása, amelyekben kifejeződik egy emlős-adenovírus E1 génjének a funkciója, és amely sejtek permisszívek azemlős cirkovírusok replikációja szempontjából; b) az emlős cirkovirus-genom - vagy egy replikációra alkalmas részének - a bejuttatása azemlített emlőssejtekbe; és c) az említett emlőssejtek tenyésztéseolyan körülmények között, amelyek megfelelőek az említettemlőscirkovírus replikációja szempontjából. Ó
HU0500161A 2001-03-27 2002-03-27 Methods to culture circovirus HU228065B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27917301P 2001-03-27 2001-03-27
PCT/CA2002/000413 WO2002077210A2 (en) 2001-03-27 2002-03-27 Methods to culture circovirus

Publications (3)

Publication Number Publication Date
HUP0500161A2 true HUP0500161A2 (hu) 2005-05-30
HUP0500161A3 HUP0500161A3 (en) 2010-01-28
HU228065B1 HU228065B1 (en) 2012-09-28

Family

ID=23067939

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0500161A HU228065B1 (en) 2001-03-27 2002-03-27 Methods to culture circovirus

Country Status (24)

Country Link
US (3) US6794163B2 (hu)
EP (1) EP1379671B1 (hu)
JP (1) JP4038127B2 (hu)
KR (1) KR100876629B1 (hu)
CN (2) CN1840656B (hu)
AT (1) ATE430807T1 (hu)
AU (1) AU2002244584B2 (hu)
BR (1) BRPI0208456B8 (hu)
CA (1) CA2442135C (hu)
CY (1) CY1109267T1 (hu)
CZ (1) CZ304525B6 (hu)
DE (1) DE60232234D1 (hu)
DK (1) DK1379671T3 (hu)
ES (1) ES2324466T3 (hu)
HU (1) HU228065B1 (hu)
MX (1) MXPA03008810A (hu)
MY (2) MY148759A (hu)
PL (1) PL202951B1 (hu)
PT (1) PT1379671E (hu)
RU (2) RU2312142C2 (hu)
SK (1) SK287969B6 (hu)
UA (1) UA82647C2 (hu)
WO (1) WO2002077210A2 (hu)
ZA (1) ZA200307517B (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US20040062775A1 (en) * 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
ES2170622B1 (es) * 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
DK1379671T3 (da) 2001-03-27 2009-06-29 Univ Saskatchewan Fremgangsmåder til dyrkning af circovirus
US20030096377A1 (en) * 2001-06-28 2003-05-22 Virginia Tech Intellectual Properties, Inc. Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
JP5394750B2 (ja) * 2005-12-29 2014-01-22 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド 多価ｐｃｖ２免疫原性組成物及び当該組成物を製造する方法
MX338626B (es) 2005-12-29 2016-04-26 Boehringer Ingelheim Vetmed Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
WO2008073464A2 (en) 2006-12-11 2008-06-19 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
PL2481420T3 (pl) * 2006-12-15 2019-08-30 Boehringer Ingelheim Animal Health USA Inc. Jednodawkowa szczepionka anty-PCV2 dla świń
EP1941903A1 (en) * 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
DK2155246T3 (da) * 2007-05-11 2013-04-02 Temasek Life Sciences Lab Ltd Fremstilling af en homogen cellelinje højtolerant til porcine circovirus type 2 (pcv2)-infektion
WO2008151215A1 (en) * 2007-06-04 2008-12-11 Merial Limited Production of porcine circovirus proteins in plants
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
ME01156B (me) * 2007-12-21 2013-03-20 Zoetis Services Llc Postupci i kompozicije za imunizaciju svinja protiv svinjskog cirkovirusa
CN101932336B (zh) * 2007-12-31 2014-07-09 贝林格尔.英格海姆维特梅迪卡有限公司 有外来氨基酸插入的pcv2 orf2病毒样颗粒
CN101980720A (zh) 2008-01-23 2011-02-23 贝林格尔.英格海姆维特梅迪卡有限公司 Pcv2猪肺炎支原体致免疫组合物及其制备方法
BRPI0911200A2 (pt) * 2008-04-16 2016-07-05 Virginia Tech Intelectual Properties Inc circovírus suíno quimérico pcv2gen-1 rep e usos do mesmo
TWI627281B (zh) * 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
US20120100168A1 (en) * 2010-01-25 2012-04-26 Blood Systems, Inc. Cyclovirus and methods of use
BR112016006192A2 (pt) 2013-09-25 2017-09-26 Zoetis Services Llc composição de vacina de divergente de pcv2b e métodos de uso
ES2778425T3 (es) 2013-10-02 2020-08-10 Boehringer Ingelheim Animal Health Usa Inc Variante de la proteína ORF2 del PCV2 y partículas similares a virus compuestas por esta
US9944904B2 (en) * 2015-05-14 2018-04-17 Merial Inc. Method for porcine circovirus production and PCV2 vaccines
US10462620B2 (en) * 2016-10-11 2019-10-29 Orion Labs Group communication forwarding to a secondary service
CN114934020B (zh) * 2022-01-30 2024-02-13 山东省滨州畜牧兽医研究院 猪视网膜上皮细胞系及其建立方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100780158B1 (ko) * 1996-10-23 2007-11-27 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 면역 치료법 및 개량 백신
AUPO856097A0 (en) 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
US6517843B1 (en) * 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US7192594B2 (en) 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
WO1999045956A1 (en) 1998-03-13 1999-09-16 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
US6492343B1 (en) 1998-04-15 2002-12-10 University Of Saskatchewan Porcine adenovirus type 3 genome
DE69941786D1 (de) 1998-09-08 2010-01-21 Brij P Giri Chemolumineszente 1,2-dioxetane
AU780822B2 (en) 1998-11-02 2005-04-21 University Of Saskatchewan Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
FR2789695B1 (fr) 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
US6497883B1 (en) 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
CA2413265A1 (en) 2000-05-03 2001-11-08 University Of Guelph Porcine adenovirus type 5 vector and vaccine
DK1379671T3 (da) 2001-03-27 2009-06-29 Univ Saskatchewan Fremgangsmåder til dyrkning af circovirus

Also Published As

Publication number Publication date
WO2002077210A3 (en) 2003-08-21
JP2005500822A (ja) 2005-01-13
BRPI0208456B8 (pt) 2021-05-25
BR0208456A (pt) 2004-03-02
US7560278B2 (en) 2009-07-14
BRPI0208456B1 (pt) 2016-10-18
KR100876629B1 (ko) 2009-01-07
ATE430807T1 (de) 2009-05-15
HU228065B1 (en) 2012-09-28
WO2002077210A2 (en) 2002-10-03
CN1840656A (zh) 2006-10-04
UA82647C2 (uk) 2008-05-12
US20050239187A1 (en) 2005-10-27
US7172899B2 (en) 2007-02-06
CZ20032584A3 (en) 2004-03-17
EP1379671B1 (en) 2009-05-06
SK12102003A3 (sk) 2004-05-04
AU2002244584B2 (en) 2006-12-14
PT1379671E (pt) 2009-07-20
CA2442135A1 (en) 2002-10-03
CZ304525B6 (cs) 2014-06-18
ZA200307517B (en) 2004-09-27
US20020177216A1 (en) 2002-11-28
DK1379671T3 (da) 2009-06-29
CN1625598A (zh) 2005-06-08
DE60232234D1 (de) 2009-06-18
MY148759A (en) 2013-05-31
KR20040002881A (ko) 2004-01-07
ES2324466T3 (es) 2009-08-07
CA2442135C (en) 2008-08-19
US20070128700A1 (en) 2007-06-07
US6794163B2 (en) 2004-09-21
MY146518A (en) 2012-08-15
CY1109267T1 (el) 2014-07-02
RU2003131342A (ru) 2005-04-20
EP1379671A2 (en) 2004-01-14
RU2312142C2 (ru) 2007-12-10
JP4038127B2 (ja) 2008-01-23
MXPA03008810A (es) 2004-02-17
SK287969B6 (sk) 2012-08-06
HUP0500161A3 (en) 2010-01-28
PL202951B1 (pl) 2009-08-31
RU2007110808A (ru) 2008-09-27
CN1309836C (zh) 2007-04-11
PL364077A1 (en) 2004-12-13
CN1840656B (zh) 2010-06-02

Similar Documents

Publication Publication Date Title
HUP0500161A2 (hu) Cirkovírusok tenyésztésére szolgáló eljárás
Folmes et al. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS
Terai et al. Immortalization of human fetal cells: the life span of umbilical cord blood-derived cells can be prolonged without manipulating p16INK4a/RB braking pathway
IL162722A (en) A method for in vitro detection of women's cervical abnormal cells and its performance
Xing et al. A comprehensive study on donor‐matched comparisons of three types of mesenchymal stem cells‐containing cells from human dental tissue
WO2000006705A3 (de) Genetisch modifizierte cd34-negative, adhärent wachsende stammzellen und deren verwendung in der gentherapie
HUP0500477A2 (hu) Eljárások és készítmények embrionális és felnőttkori őssejtek támogatására stromasejtek alkalmazásával
IS6373A (is) Mannafósturfrumur, sérhæfðar í blóðmyndandi frumur
DE60216959D1 (de) Sich in schlagende kardiomyozyten verwandelnde stammzellen
EP1360314A4 (en) CHEMICALLY DEFINED MEDIUM FOR CULTIVATED MAMMALIAN CELLS
HUP0103485A2 (hu) A kivánt fehérjék túlexpressziója eukarióta sejtekben, a D1 ciklin túlexpressziójával vezérelve
DK1650307T3 (da) Fremgangsmåde til fremstilling af rekombinante proteiner ved anvendelse af apoptoseinhibitorer
WO2007016366A3 (en) Defined culture conditions of human embryonic stem cells
Luo et al. Base editing in bovine embryos reveals a species-specific role of SOX2 in regulation of pluripotency
Brayton et al. Further characterization of mouse hepatitis virus RNA-dependent RNA polymerases
Zhong et al. Barhl1 is required for the differentiation of inner ear hair cell-like cells from mouse embryonic stem cells
Lei et al. Calreticulin as a special marker to distinguish dental pulp stem cells from gingival mesenchymal stem cells
Claydon et al. Attempts at immortalization of crustacean primary cell cultures using human cancer genes
AU2002361797A1 (en) Cell lines with latent immunodeficiency virus and methods of use thereof
Brison et al. RT‐PCR‐based method to localize the spatial expression of genes in the mouse blastocyst
Javidpou et al. Mesenchymal stem/stromal-like cells from diploid and triploid human embryonic stem cells display different gene expression profiles
WO2004078916A3 (en) In vitro micro-organs, and uses related thereto
Hajizadeh-Tafti et al. Established Yazd human foreskin fibroblast lines (# 8,# 17, and# 18) displaying similar characteristics to mesenchymal stromal cells: A lab resources report
Janz et al. CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM)
HUP0400150A2 (en) Saponin-digesting enzymes, genes thereof and soyasapogenol b mass production system